Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the PEG ratio high or low?
The PEG ratio of 1.40 is 35% above its 4-year average of 1.03, near the high end of its 4-year range (0.68–1.50).
As of 2026-10-06T14:26:41.144Z. 14.41% above its 12-month average of 1.22.
Calculation as of: 2026-10-06T14:26:41.144Z.
Quote observation: 2026-10-06T14:25:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a1fa914b4487e4ae5c9b7a635cce1df0c30efb2543a97d65c3cd252c667dccf4
PEG RATIO
1.40
PEG RATIO AVG TTM
1.22
PEG RATIO AVG 3Y
1.05
PEG RATIO AVG 5Y
N/A
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+14.41%
CURRENT VS 3Y AVG
+33.02%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.83
median of 58 covered companies
CURRENT VS SECTOR MEDIAN
-23.50%
vs the sector median at left
Market Cap
$12.53B
PEG Ratio
N/A
TTM Avg
6.43
3Y Avg
5.04
5Y Avg
3.49
Market Cap
$12.52B
PEG Ratio
0.98
TTM Avg
1.07
3Y Avg
1.07
5Y Avg
1.07
Market Cap
$12.14B
PEG Ratio
1.40
TTM Avg
2.72
3Y Avg
36.33
5Y Avg
61.65
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | $12.79B | 1.40 | 1.22 | 1.05 | N/A |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.91B | N/A | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.64B | N/A | 2.64 | 6.31 | 6.30 |
| Corcept Therapeutics Incorporated (CORT)vs › | $12.53B | N/A | 6.43 | 5.04 | 3.49 |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.52B | 0.98 | 1.07 | 1.07 | 1.07 |
| Penumbra, Inc. (PEN)vs › | $12.50B | N/A | 4.12 | 4.12 | 4.12 |
| Baxter International Inc. (BAX)vs › | $12.41B | N/A | 3.72 | 3.63 | 3.63 |
| Encompass Health Corporation (EHC)vs › | $12.14B | 1.40 | 2.72 | 36.33 | 61.65 |
| Tempus AI, Inc. (TEM)vs › | $13.71B | N/A | N/A | N/A | N/A |
| Ascendis Pharma A/S (ASND)vs › | $13.95B | N/A | N/A | N/A | N/A |
PEG Ratio
1.40
P/E Ratio
32.2
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2026-10-05 | 1.41 |
| 2026-10-02 | 1.43 |
| 2026-10-01 | 1.39 |
| 2026-09-30 | 1.43 |
| 2026-09-29 | 1.45 |
| 2026-09-28 | 1.47 |
| 2026-09-25 | 1.48 |
| 2026-09-24 | 1.50 |
| 2026-09-23 | 1.46 |
| 2026-09-22 | 1.50 |
| 2026-09-21 | 1.45 |
| 2026-09-18 | 1.46 |
| 2026-09-17 | 1.42 |
| 2026-09-16 | 1.41 |
| 2026-09-15 | 1.38 |
| 2026-09-14 | 1.40 |
| 2026-09-11 | 1.39 |
| 2026-09-10 | 1.39 |
| 2026-09-09 | 1.39 |
| 2026-09-08 | 1.41 |
| 2026-09-04 | 1.43 |
| 2026-09-03 | 1.44 |
| 2026-09-02 | 1.42 |
| 2026-09-01 | 1.40 |
| 2026-08-31 | 1.38 |
| 2026-08-28 | 1.37 |
| 2026-08-27 | 1.39 |
| 2026-08-26 | 1.39 |
| 2026-08-25 | 1.42 |
| 2026-08-24 | 1.41 |
| 2026-08-21 | 1.41 |
| 2026-08-20 | 1.38 |
| 2026-08-19 | 1.40 |
| 2026-08-18 | 1.36 |
| 2026-08-17 | 1.34 |
| 2026-08-14 | 1.28 |
| 2026-08-13 | 1.31 |
| 2026-08-12 | 1.32 |
| 2026-08-11 | 1.33 |
| 2026-08-10 | 1.33 |
| 2026-08-07 | 1.34 |
| 2026-08-06 | 1.34 |
| 2026-08-05 | 1.31 |
| 2026-08-04 | 1.30 |
| 2026-08-03 | 1.29 |
| 2026-07-31 | 1.29 |
| 2026-07-30 | 1.30 |
| 2026-07-29 | 1.30 |
| 2026-07-28 | 1.31 |
| 2026-07-27 | 1.28 |
| 2026-07-24 | 1.28 |
| 2026-07-23 | 1.27 |
| 2026-07-22 | 1.22 |
| 2026-07-21 | 1.23 |
| 2026-07-20 | 1.21 |
| 2026-07-17 | 1.22 |
| 2026-07-16 | 1.21 |
| 2026-07-15 | 1.19 |
| 2026-07-14 | 1.17 |
| 2026-07-13 | 1.19 |
| 2026-07-10 | 1.19 |
| 2026-07-09 | 1.23 |
| 2026-07-08 | 1.26 |
| 2026-07-07 | 1.28 |
| 2026-07-06 | 1.26 |
| 2026-07-02 | 1.24 |
| 2026-07-01 | 1.21 |
| 2026-06-30 | 1.23 |
| 2026-06-29 | 1.21 |
| 2026-06-26 | 1.17 |
| 2026-06-25 | 1.14 |
| 2026-06-24 | 1.11 |
| 2026-06-23 | 1.09 |
| 2026-06-22 | 1.08 |
| 2026-06-18 | 1.07 |
| 2026-06-17 | 1.07 |
| 2026-06-16 | 1.09 |
| 2026-06-15 | 1.12 |
| 2026-06-12 | 1.09 |
| 2026-06-11 | 1.11 |
| 2026-06-10 | 1.10 |
| 2026-06-09 | 1.12 |
| 2026-06-08 | 1.11 |
| 2026-06-05 | 1.12 |
| 2026-06-04 | 1.12 |
| 2026-06-03 | 1.09 |
| 2026-06-02 | 1.04 |
| 2026-06-01 | 1.07 |
| 2026-05-29 | 1.04 |
| 2026-05-28 | 1.07 |
| 2026-05-27 | 1.07 |
| 2026-05-26 | 1.08 |
| 2026-05-22 | 1.07 |
| 2026-05-21 | 1.07 |
| 2026-05-20 | 1.08 |
| 2026-05-19 | 1.08 |
| 2026-05-18 | 1.06 |
| 2026-05-15 | 1.05 |
| 2026-05-14 | 1.08 |
| 2026-05-13 | 1.10 |
| 2026-05-12 | 1.11 |
| 2026-05-11 | 1.16 |
| 2026-05-08 | 1.12 |
| 2026-05-07 | 1.14 |
| 2026-05-06 | 1.16 |
| 2026-05-05 | 1.15 |
| 2026-05-04 | 1.13 |
| 2026-05-01 | 1.12 |
| 2026-04-30 | 1.11 |
| 2026-04-29 | 1.10 |
| 2026-04-28 | 1.12 |
| 2026-04-27 | 1.13 |
| 2026-04-24 | 1.14 |
| 2026-04-23 | 1.16 |
| 2026-04-22 | 1.20 |
| 2026-04-21 | 1.20 |
| 2026-04-20 | 1.22 |
| 2026-04-17 | 1.21 |
| 2026-04-16 | 1.16 |
| 2026-04-15 | 1.19 |
| 2026-04-14 | 1.18 |
| 2026-04-13 | 1.17 |
| 2026-04-10 | 1.19 |
| 2026-04-09 | 1.17 |
| 2026-04-08 | 1.14 |
| 2026-04-07 | 1.11 |
| 2026-04-06 | 1.10 |
| 2026-04-02 | 1.13 |
| 2026-04-01 | 1.14 |
| 2026-03-31 | 1.13 |
| 2026-03-30 | 1.09 |
| 2026-03-27 | 1.08 |
| 2026-03-26 | 1.11 |
| 2026-03-25 | 1.11 |
| 2026-03-24 | 1.08 |
| 2026-03-23 | 1.10 |
| 2026-03-20 | 1.11 |
| 2026-03-19 | 1.11 |
| 2026-03-18 | 1.11 |
| 2026-03-17 | 1.14 |
| 2026-03-16 | 1.12 |
| 2026-03-13 | 1.11 |
| 2026-03-12 | 1.11 |
| 2026-03-11 | 1.16 |
| 2026-03-10 | 1.19 |
| 2026-03-09 | 1.19 |
| 2026-03-06 | 1.18 |
| 2026-03-05 | 1.18 |
| 2026-03-04 | 1.22 |
| 2026-03-03 | 1.21 |
| 2026-03-02 | 1.22 |
| 2026-02-27 | 1.22 |
| 2026-02-26 | 1.21 |
| 2026-02-25 | 1.23 |
| 2026-02-24 | 1.23 |
| 2026-02-23 | 1.23 |
| 2026-02-20 | 1.24 |
| 2026-02-19 | 1.26 |
| 2026-02-18 | 1.28 |
| 2024-02-20 | 0.73 |
| 2024-02-16 | 0.73 |
| 2024-02-15 | 0.73 |
| 2024-02-14 | 0.71 |
| 2024-02-13 | 0.70 |
| 2024-02-12 | 0.72 |
| 2024-02-09 | 0.72 |
| 2024-02-08 | 0.72 |
| 2024-02-07 | 0.72 |
| 2024-02-06 | 0.71 |
| 2024-02-05 | 0.68 |
| 2024-02-02 | 0.68 |
| 2024-02-01 | 0.70 |
| 2024-01-31 | 0.69 |
| 2024-01-30 | 0.69 |
| 2024-01-29 | 0.70 |
| 2024-01-26 | 0.69 |
| 2024-01-25 | 0.70 |
| 2024-01-24 | 0.71 |
| 2024-01-23 | 0.71 |
| 2024-01-22 | 0.69 |
| 2024-01-19 | 0.69 |
| 2024-01-18 | 0.71 |
| 2024-01-17 | 0.73 |
| 2024-01-16 | 0.74 |
| 2024-01-12 | 0.70 |
| 2024-01-11 | 0.69 |
| 2024-01-10 | 0.70 |
| 2024-01-09 | 0.71 |
| 2024-01-08 | 0.72 |
| 2024-01-05 | 0.71 |
| 2024-01-04 | 0.74 |
| 2024-01-03 | 0.73 |
| 2024-01-02 | 0.76 |
| 2023-12-29 | 0.75 |
| 2023-12-28 | 0.75 |
| 2023-12-27 | 0.75 |
| 2023-12-26 | 0.76 |
| 2023-12-22 | 0.75 |
| 2023-12-21 | 0.75 |
| 2023-12-20 | 0.74 |
| 2023-12-19 | 0.80 |
| 2023-12-18 | 0.79 |
| 2023-12-15 | 0.79 |
| 2023-12-14 | 0.80 |
| 2023-12-13 | 0.85 |
| 2023-12-12 | 0.82 |
| 2023-12-11 | 0.82 |
| 2023-12-08 | 0.81 |
| 2023-12-07 | 0.82 |
| 2023-12-06 | 0.81 |
| 2023-12-05 | 0.81 |
| 2023-12-04 | 0.81 |
| 2023-12-01 | 0.81 |
| 2023-11-30 | 0.78 |
| 2023-11-29 | 0.78 |
| 2023-11-28 | 0.81 |
| 2023-11-27 | 0.83 |
| 2023-11-24 | 0.82 |
| 2023-11-22 | 0.81 |
| 2023-11-21 | 0.79 |
| 2023-11-20 | 0.81 |
| 2023-11-17 | 0.81 |
| 2023-11-16 | 0.80 |
| 2023-11-15 | 0.80 |
| 2023-11-14 | 0.82 |
| 2023-11-13 | 0.76 |
| 2023-11-10 | 0.76 |
| 2023-11-09 | 0.74 |
| 2023-11-08 | 0.75 |
| 2023-11-07 | 0.79 |
| 2023-11-06 | 0.79 |
| 2023-11-03 | 0.79 |
| 2023-11-02 | 0.76 |
| 2023-11-01 | 0.75 |
| 2023-10-31 | 0.76 |
| 2023-10-30 | 0.76 |
| 2023-10-27 | 0.75 |
| 2023-10-26 | 0.77 |
| 2023-10-25 | 0.74 |
| 2023-10-24 | 0.78 |
| 2023-10-23 | 0.78 |
| 2023-10-20 | 0.78 |
| 2023-10-19 | 0.80 |
| 2023-10-18 | 0.80 |
| 2023-10-17 | 0.84 |
| 2023-10-16 | 0.83 |
| 2023-10-13 | 0.82 |
| 2023-10-12 | 0.82 |
| 2023-10-11 | 0.83 |
| 2023-10-10 | 0.85 |
| 2023-10-09 | 0.83 |
| 2023-10-06 | 0.83 |
| 2023-10-05 | 0.84 |
| 2023-10-04 | 0.83 |
| 2023-10-03 | 0.84 |
| 2023-10-02 | 0.84 |
| 2023-09-29 | 0.85 |
| 2023-09-28 | 0.87 |
| 2023-09-27 | 0.86 |
| 2023-09-26 | 0.86 |
Showing the most recent 260 of 409 data points. The chart above shows the full history.
